Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Molecular Cancer Therapeutics|February 8, 2014
Combination of imatinib with CXCR4 antagonist BKT140 overcomes the protective effect of stroma and targets CML in vitro and in vivoKatia Beider, Merav Darash-Yahana, Orly Blaier, et al.
Plos One|September 28, 2011
Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progressionSophie Kirshberg, Uzi Izhar, Gail Amir, et al.
European Journal of Immunology|April 29, 2004
Differential usage of VLA-4 and CXCR4 by CD3+CD56+ NKT cells and CD56+CD16+ NK cells regulates their interaction with endothelial cellsSuzanna Franitza, Valentin Grabovsky, Ori Wald, et al.
Molecular Therapy. Nucleic Acids|January 9, 2023
Multiplex HDR for disease and correction modeling of SCID by CRISPR genome editing in human HSPCsOrtal Iancu, Daniel Allen, Orli Knop, et al.
Plos One|April 3, 2009
Interaction between CXCR4 and CCL20 pathways regulates tumor growthKatia Beider, Michal Abraham, Michal Begin, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 29, 2012
In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancerDuha Fahham, Ido D Weiss, Michal Abraham, et al.
Bone Marrow Transplantation|December 3, 2020
Immune imitation of tumor progression after anti-CD19 chimeric antigen receptor T cells treatment in aggressive B-cell lymphomaIvetta Danylesko, Roni Shouval, Noga Shem-Tov, et al.
Pageof 5